biobanking | GenomeWeb

biobanking

The partners will work together to create a cancer research biobank to help advance Northwell's precision medicine efforts.

The partners have opened a new biorepository that will engage with clinical researchers and foster future personalized medicine efforts in the German capital.

The center, which is seen as a bellwether for integrating genomic information with EMRs, will use the data to inform efforts to prevent chronic, common diseases.

Mount Sinai is the latest healthcare provider to link up with Regeneron's Genetics Center, to pair NGS data with electronic medical record data.

The biobank will also provide lab services to researchers, academic institutions, pharmaceutical firms, and contract research organizations worldwide.

Proponents believe the Million European Genomes Alliance will spur research, stimulate the life sciences economy, and ultimately improve clinical care.

PNRI researchers will be able to analyze information from over 600,000 discrete tumor, blood, and urine samples from around 25,000 patients.

The Human Cancer Models Initiative aims to create about 1,000 cancer cell lines that scientists can use to study tumor progression, drug resistance, and more.

The agency said it would disperse the funds to the clinic over the course of five years to collect, store, and distribute biospecimens for precision medicine research.

The healthcare provider plans to build a large biobank to conduct precision medicine research based on genomics, lifestyle, and environmental factors. 

Pages

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.